Results 41 to 50 of about 43,493 (251)

The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura

Gut and Liver, 2015
Background/Aims The aim of this study was to evaluate the ability of Helicobacter pylori eradication treatment to increase platelet counts in Korean patients with chronic idiopathic thrombocytopenic purpura (ITP).
J. Hwang, D. H. Lee, H. Yoon, C. Shin, Y. Park, Nayoung Kim   +5 more
semanticscholar   +1 more source

A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery

Transfusion, EarlyView.
Abstract Background Cardiac surgery on cardiopulmonary bypass (CPB) may alter platelet (PLT) function causing bleeding. The goal of this study is to evaluate the hemostatic effect of PRT‐PLTs compared to untreated PLTs stored in platelet additive solution (PAS) following transfusion in bleeding patients undergoing cardiac surgery on CPB.
Magali J. Fontaine, Jackline J. M. Lasola, Aidaelis Martinez‐Hernandez, Juliana N. Marshall, Soren Bentzen, Min Zhan, Parvez M. Lokhandwala, Kenichi Tanaka, Carlos H. Villa, Alexis Jones, Chintamani D. Atreya, Reney A. Henderson   +11 more
wiley   +1 more source

Abnormal Uterine Bleeding and External Genital Endometriosis in a 14-Year-Old Patient with Idiopathic Thrombocytopenic Purpura: Case Report

Педиатрическая фармакология
Background. Idiopathic Thrombocytopenic Purpura is one of the most common acquired blood-clotting disorders in adolescents. This disease is characterized by an increased risk of developing concomitant gynecological pathologies, such as abnormal uterine ...
Elena V. Sibirskaya, Irina V. Karachentsova, Aliya Yu. Kurmangaleeva, Aina S. Annakulieva   +3 more
doaj   +1 more source

Multiple splenic artery aneurysms in a patient with idiopathic thrombocytopenic purpura: A case report, brief literature review and discussion

Artery Research, 2010
Multiple splenic artery aneurysms in a patient with idiopathic thrombocytopenic purpura: A case report, brief literature review and discussion.
David Busel, Alonso Yanez, Edgard Jimenez, Christopher K. Johansen   +3 more
doaj   +1 more source

BMQ [PDF]

, 1963
BMQ: Boston Medical Quarterly was published from 1950-1966 by the Boston University School of Medicine and the Massachusetts Memorial ...
Antuna, Juan, Bagnoli, Thomas, Barber, Doris E., Cocchiarella, John P., Duke, Martin, Estes, J. Worth, Friedlander, Walter J., Goldsmith, Harry S., Gooding, Gretchen W., Goofman, Max L., Haseotes, Hytho V., Hass, Gerald, Hastings, A. Baird, Jackson, David R., Johnson, David S., Kechejian, Sarkis J., Kramer, Philip, Litman, George I., Madoff, Irving M., McLellan, Patricia A., O'Hara, Vincent S., Peabody, C. Newton, Pryles, Charles V., Small, Donald M., Tedeschi, Luke G., Walker, Sydney, III   +25 more
core  

Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. [PDF]

, 2008
Idiopathic thrombocytopenic purpura (ITP) is characterized by a low platelet count, which is the result of both increased pla- telet destruction and insufficient platelet production.
Amadori, S, Buccisano, F, Evangelista, M, Stasi, R, Stipa, E, Venditti, A   +5 more
core   +1 more source

Immunosuppressive and Non‐Immunosuppressive Drugs for Heart Xenotransplantation in Humans: Is Europe Ready?

Xenotransplantation, Volume 32, Issue 4, July/August 2025.
ABSTRACT Xenotransplantation is becoming an emerging field of interest for the treatment of end‐stage heart disease. In fact, the shortage of human heart donors in European countries requires the increasing investigation of alternative strategies such as heart xenotransplantation.
Nicola Pradegan, Annamaria Tolomeo, Diego Ciccarelli, Emanuele Cozzi, Antonio Vitiello, Andrea Zovi, Gino Gerosa   +6 more
wiley   +1 more source

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura : A Single Technology Appraisal [PDF]

, 2008
Evidence Review Group (ERG) final report for the National Institute for Health and Clinical ExcellencePublisher ...
Boyers, Dwayne, Crowther, M, Fraser, Cynthia Mary, Jenkinson, David James, Jia, Xueli, Mowatt, Graham   +5 more
core  

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

Haematologica, 2008
Rituximab 375 mg/m2 weekly for four weeks has significant activity in patients with immune thrombocytopenia. We evaluated the activity of lower dose rituximab (100 mg iv weekly for 4 weeks) in 28 adults with idiopathic thrombocytopenic purpura.
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, Salvatore Palmieri, Michela Montagna, Nicola Vianelli, Luciana Marin, Margherita Cavallin, Monica Bocchia, Marzia Defina, Micaela Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria Antonietta Avanzini, Mario Regazzi, Michele Baccarani, Miriam Isola, Franca Soldano, Renato Fanin   +18 more
doaj   +1 more source

Hetrombopag: A promising thrombopoietin receptor agonist for the treatment of primary and secondary immune thrombocytopenia

Rheumatology &Autoimmunity, Volume 5, Issue 2, Page 101-115, June 2025.
This review seeks to provide a thorough synthesis of the existing literature on the role of thrombopoietin receptor agonists in the treatment of primary and secondary immune thrombocytopenia, with particular emphasis on the compound Hetrombopag. Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below
Jiaqi Hu, Zhida Fu, Xia Xu, Zhengyi Jin, Xinyu Qian, Weiyu Tao, Taiyan Ma, Dongbao Zhao, Jie Gao   +8 more
wiley   +1 more source